← All organizations
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2009Last known activity
Aug 9, 2024
Timeline
1990s
- Jan 1, 1996
Shanghai Zhangjiang Biotechnology Limited Company— Founded
Drugs by trial phase (23 distinct, 25 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Carcinoma in Situ
- Carcinoma, Ovarian Epithelial
- Cervical Intraepithelial Neoplasia
- Collagen Diseases
- Colorectal Neoplasms
- Communicable Diseases
- Hemangioma, Capillary
- Infections
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Neoplasms
- Ovarian Neoplasms
- Papillomavirus Infections
- Port-Wine Stain
- Rheumatic Diseases
- Squamous Intraepithelial Lesions of the Cervix
Recent trials (32)
- NCT06519370Lead sponsorPhase 3Aug 9, 2024
- NCT06424665Lead sponsorPhase 1Jul 3, 2024
- NCT06417281Lead sponsorPhase 3Jun 19, 2024
- NCT06413615Lead sponsorPhase 2May 13, 2024
- NCT05914545Lead sponsorPhase 1Jun 12, 2023
- NCT05171894Lead sponsorPhase 2Dec 30, 2022
- NCT05564858Lead sponsorPhase 1Oct 31, 2022
- NCT05174637Lead sponsorPhase 1Oct 22, 2021
- NCT06715319Lead sponsorPhase 3Oct 9, 2021
- NCT06439433Lead sponsorPhase 2May 31, 2021
- NCT04715529Lead sponsorPhase 1Jan 27, 2021
- NCT04106258Lead sponsorPhase 4Oct 31, 2019
- NCT03894150Lead sponsorPhase 1Apr 11, 2019
- NCT03181984Study directorPhase 4Jun 1, 2017
- NCT03181984Lead sponsorPhase 4Jun 1, 2017
Details
- Founded
- Pudong, CN Jan 1, 1996
- Last known activity
- Aug 9, 2024
Notes
--- Pre-folding founded info: 1996-06-01 Shanghai None China http://www.hoovers.com/company-information/cs/company-profile.shanghai_zhangjiang_biotechnology_co_ltd.d9a1b0c98080a528.html?aka_re=1 ---